Table 5. Comparison of effects of different variables on OS of patients after transplantation.
| Effects | Event(death)/total | p value |
|---|---|---|
| Patient age at transplant | ||
| <15 yr | 2/49 | 0.043 |
| ≥15 yr | 5/28 | |
| Diagnosis-to-transplant interval | ||
| ≤6 months | 1/38 | 0.036 |
| >6 months | 6/39 | |
| Patient sex | 0.249 | |
| Female | 2/38 | |
| Male | 5/39 | |
| IST prior to referral for HSCT | ||
| ATG included | 2/15 | 0.524 |
| ATG excluded | 5/62 | |
| Transfusion RBC before HSCT | ||
| ≥25U | 4/29 | 0.265 |
| <25U | 3/48 | |
| Infused MNC cells | ||
| ≤8×108/kg | 3/11 | 0.023 |
| >8×108/kg | 4/66 | |
| Infused CD34+ cells | 0.076 | |
| ≤3×106/kg | 3/14 | |
| >3×106/kg | 4/63 | |
| Conditioning regimen | 0.721 | |
| A(Flu+Cy+ATG+Bu) | 4/42 | |
| B(Flu+Cy+ATG) | 3/35 | |
| Time to neutrophil engraftment | ||
| ≥12 days | 4/40 | 0.773 |
| <12 days | 3/37 | |
| Time to platelet engraftment | 0.423 | |
| ≥14 days | 5/44 | |
| <14 days | 2/33 | |
| aGVHD | 0.001 | |
| No/Grades I-II | 3/69 | |
| Grades III-IV | 4/8 | |
| cGVHD | 0.001 | |
| No/Limited | 4/72 | |
| Extensive | 3/5 | |
| Donor age | 0.037 | |
| <45 yr | 4/65 | |
| ≥45 yr | 3/12 | |
| D-R sex match | 0.684 | |
| Match | 4/48 | |
| Mismatch | 3/29 | |
| D-R major blood group match | 0.468 | |
| Match | 3/43 | |
| Mismatch | 4/34 | |
| D-R HLA mismatched | 0.508 | |
| 2-4 HLA loci | 2/31 | |
| 5 HLA loci | 5/46 |
D-R, donor-recipient.